CPSI BIOTECH Management Team

CPSI Biotech has a strong management and advisory team which has overseen the development of the various technologies in the pipeline.  The team is comprised of internationally recognized individuals who have a demonstrated track record in technology innovation, development, commercialization, and sales and marketing. Collectively through previous experiences, this team has overseen the development, introduction, and marketing of over two dozen medical devices and disposables in the cryosurgical arena.

Current key team members include:

  • John M. Baust, Ph.D. President & CEO Lead Scientist & Engineer, Founder

John M. Baust, Ph.D. is the founder, director, CEO, President and Lead Scientist of CPSI Biotech.  Dr. Baust has 15+ years’ experience in medical device development and is a co-inventor on 30 patents.  Dr. Baust completed his studies at Cornell University, State University of New York at Binghamton and Harvard Medical School.  Dr. Baust is a recognized innovator and entrepreneur in cryomedicine and cancer therapy and is a pioneer in the area of molecular mechanisms of cell death as they relate to low temperature stress.  Through his previous work, Dr. Baust has been involved with the development and commercialization of several new products.  He has authored and co-authored over 100 papers, reviews, book chapters, abstracts and patents in the area of the low temperature biology and has been instrumental in the advancement of the field of cryobiology into the molecular biological era focusing in the areas of signal transduction and apoptosis.  In addition to his research and business activities, Dr. Baust has served on the editorial board for Biopreservation and Biobanking and is the co-Editor of the book Advances in Biopreservationand is a current board member for the American College of Cryosurgery.

  • Kristi Snyder, Ph.D.  Director of Operations and Life Science Research

Kristi Snyder, Ph.D. currently serves as a Principal Scientist and the Director of Operations at CPSI Biotech.  She has been with CPSI Biotech since its formation, overseeing the daily operations of the life science division and general corporate administration.  Dr. Snyder earned her Bachelor’s from Cornell University (Biological Sciences) and completed her Ph.D. in Cellular and Molecular Biology at Binghamton University, examining the responses of mammalian cardiac systems to low temperature exposure. Her published works include chapters in several key reference texts and authorship on dozens of peer-reviewed articles and abstracts in cryobiology.  She has also provided training and educational seminars throughout the US and Europe on critical temperature-based in vitro techniques.  Dr. Snyder leads the life science activities at CPSI Biotech and serves as a principal investigator of several NIH SBIR grants.

  • Robert Van Buskirk, Ph.D. Vice President of R&D – Grants Development

Dr. Van Buskirk currently serves as Vice President of Research – Grants Development for CPSI.  Dr Van Buskirk has been with CPSI for over 10 years and oversees CPSI’s NIH SBIR grant program which provides critical support funding for various new technology initiatives at CPSI.  In addition to his responsibilities at CPSI, Dr. Van Buskirk is also a Professor in the Department of Biology at Binghamton University.   Dr. Van Buskirk has had a long career in the biotechnology field previously serving in the capacity of consultant or Vice President at several companies.  Throughout his career, Dr. Van Buskirk has blended both experiences together such that this fusion has resulted in the development of several biotech and medtech products. Education: BS in Biology from the University of Vermont and Ph.D. from Harvard University.

  • Mr. Richard O’Hara, Comptroller

Mr. O’Hara serves as comptroller for CPSI.  Mr. O’Hara received his MBA in business form the State University of New York – Albany.  Mr. O’Hara is responsible for oversight of the accounting activities practices at CPSI.


Advisers

  • John G. Baust, Ph.D. Chief Scientific Adviser

Dr. John G. Baust has twenty years’ experience in executive management of public medical technology companies.  In 1990 Dr. Baust joined Cryomedical Sciences, Inc. (NASDQ: CMSI) as Vice President of Research & Development and was directly responsible for the development of twenty products brought to market in less than two-years.  CMSI was a start-up that grew to over 350 employees.  He later joined the Board of Directors and was named President & CEO of CMSI in 2002 to manage the sale of the company to Endocare, Inc.  In 2005 he was named President & CEO of BioLife Solutions, Inc. (NASDAQ: BLFS).  BLFS was a start-up and after five years was relocated to the west coast by its international investors.  During the transition, Dr. Baust was named Chairman of the Board to assist in training of the new management team.  Dr. Baust has worn a “second hat” during this period as Lead Professor and Director of the Institute of Biomedical Technology at the State University of New York at Binghamton where he directs multidisciplinary research programs in translational cryomedicine including areas such as cryogenic engineering, cryoablative strategies in cardiovascular disease and cancer therapy.  This academic linkage has proven invaluable to the companies he has been associated with.  Dr. Baust is the UNESCO Chair, a Distinguished Fellow of the Society for Cryobiology, a member of the American Urological Association Best Practices Panel on Cryotherapy of Localized Prostate Cancer, Past Editor-in Chief of the journal Biopreservation & Biobanking, Past President of the American College of Cryosurgery and the International Society for Cryobiology, U.S. Delegate to and Commission President of the International Institute of Refrigeration and serves on the editorial boards of various journals.  He has authored or co-authored more than 500 reviewed articles, chapters and abstracts, holds dozens of patents in cryomedicine, serves on numerous grant review panels and consults extensively with government and industry.

  • Walt Malyszek, Business Development Liaison

Mr. Malysezk recently joined CPSI Biotech as a Business Development Liaison to assist CPSI in identifying and obtaining financing to transition the various technologies developed by CPSI into the market place. He holds a Bachelor’s of Science in Microbiology from the University of Alaska, Fairbanks. Mr. Malyszek has years of experience in government contracts, business development, strategic planning and business management.